Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer

Department of Urology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
International Journal of Urology (Impact Factor: 2.41). 09/2004; 11(8):619-27. DOI: 10.1111/j.1442-2042.2004.00860.x
Source: PubMed


We performed a retrospective survey of general and disease specific health-related quality of life (HRQOL) after radical prostatectomy (RP) and external beam radiotherapy (XRT) in Japanese men.
A total of 186 patients underwent RP and 78 underwent XRT for clinically localized prostate cancer between 2000 and 2002. We measured the general and disease specific HRQOL with the MOS 36-Item Health Survey and the University of California, Los Angeles Prostate Cancer Index, respectively. Each treatment group was further divided into four subgroups according to the time scale.
Patients from the RP group were significantly younger than those from the XRT group. The tumor characteristics differed significantly in their distributions among the treatment groups. Patients undergoing XRT had low scores in most of the general measures of HRQOL just after treatment, but after 6 months there were no differences between the treatment groups, except for the physical domains. The RP group was associated with worse urinary function, whereas the XRT group had worse bowel function and bother during the first 6 months after treatment. Thereafter, however, urinary and bowel domain did not differ between the groups. Both groups reported poor sexual function, although the RP group scored lower sexual bother.
The patients who underwent RP had significantly worse urinary and better bowel function than those treated with XRT. Both treatment groups had decrements in sexual function throughout the post-treatment period; careful attention should be paid to this side-effect in preoperative counselling, especially in younger patients, regardless of the primary treatments.

Download full-text


Available from: Shunichi Namiki, Mar 30, 2015
9 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Health-related quality of life (QOL) has become a pivotal criterion for assessing quality of specific therapy for prostate and bladder cancer in urology and serves increasingly as a basis for therapeutic decisions reached by urologists and patients. To aid in comprehension, we present the development of QOL research, the accumulated knowledge, and needs for further investigations by offering a broad review of the literature. In Germany, established inpatient rehabilitation has dealt with QOL for decades, but proof of efficacy was lacking. We clearly demonstrated in a prospective study the beneficial effects on QOL achieved with a specific modular urologic inpatient rehabilitation program after radical prostatectomy within 3-4 weeks and stability of these effects over time. Inpatient rehabilitation provides the best generic and disease-specific QOL after radical urologic surgery and completes the surgeon's performance.
    Der Urologe 02/2005; 44(1):11-28. DOI:10.1007/s00120-004-0736-x · 0.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: No previous studies have reported the longitudinal health-related quality of life (HRQOL) for intensity modulated radiation therapy (IMRT). We compared HRQOL after IMRT with that after conventional and after conformal radiation therapy (XRT). A total of 110 patients underwent XRT (34 patients underwent conventional radiation therapy and 76 underwent conformal radiation therapy) and 30 underwent IMRT for clinically localized prostate cancer between 2000 and 2002. We measured the general and disease-specific HRQOL using the Medical Outcomes Study 36-Item Health Survey and University of California, Los Angeles, Prostate Cancer Index, respectively. There were no significant differences in the preoperative characteristics and HRQOL scores of the two groups. Repeated measure analyses of variance revealed significantly different patterns of alteration in several general HRQOL domains between XRT and the IMRT groups. In the urinary domain, there was no difference in the alteration patterns between the two groups. The XRT group suffered worse bowel function at 3 and 6 months than the IMRT group (P < 0.05). In the XRT group, sexual function decreased at 3 months and remained substantially lower than the baseline level. However, the IMRT group showed no significant difference from the baseline level at any of the observation periods. At 18 months the XRT group showed worse sexual function than the IMRT group. The two approaches showed different longitudinal profiles regarding general and disease-specific HRQOL during the first 2 years after treatment. The IMRT approach produced little impairment in bowel and sexual function.
    Japanese Journal of Clinical Oncology 05/2006; 36(4):224-30. DOI:10.1093/jjco/hyl002 · 2.02 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We compared health-related quality-of-life (HRQL) after intensity-modulated radiotherapy (IMRT) with statuses obtained after old and new protocols of three-dimensional conformal radiation therapy (3DCRT) for localized prostate cancer. We measured the general and disease specific HRQL using the MOS 36-Item Health Survey (SF-36), and the University of California, Los Angeles Prostate Cancer Index (UCLA PCI), respectively. IMRT resulted in similar profiles of general and disease-specific HRQL to two other methods within the first year after treatment. Moreover, IMRT gave rise to comparable urinary, intestinal and sexual side effects despite the high dose of radiation applied.
    Prostate Cancer and Prostatic Diseases 02/2007; 10(3):288-92. DOI:10.1038/sj.pcan.4500923 · 3.43 Impact Factor
Show more